Covalent conjugation of proteins with ubiquitin is one the most important post translational modifications because it controls intracellular protein trafficking typically resulting in protein degradation. Frequently ubiquitinated proteins are targeted to the proteasome for degradation in the cytosol. However, ubiquitinated membrane bound proteins can also be targeted for endocytosis and degradation in the lysosome. Ubiquitin-dependent degradation pathways have clear cancer relevance due to their integral involvement in protein quality control, regulation of immune responses, signal transduction, and cell cycle regulation. In spite of its fundamental importance, little is known regarding how proteins are specifically identified for ubiquitin-dependent degradation. In this article we review a newly discovered family of viral and cellular ubiquitin ligases called MARCH proteins. Recent studies of MARCH proteins define new paradigms showing how ubiquitin E3 ligases determine the intracellular location and fate of proteins.
KeywordsDegradation pathways; ubiquitination; intracellular trafficking; immune evasion; γherpesvirus-68; Kaposi's sarcoma-associated herpes virus
1.Substrate ubiquitinationIt has recently become appreciated that subtleties regarding the location, linkage and extent of protein ubiquitination can be key determinants controlling the fate of protein [1,2,3]. However, the basic process of ubiquitination has been highly conserved in evolution. Ubiquitination of substrates requires the catalytic cascade of three classes of proteins E1, E2, and E3 that interact sequentially to transfer ubiquitin moieties to substrates [4]. The E1, termed the ubiquitinactivating enzyme, forms a thioester bond between its active site cysteine and the carboxylterminal glycine of ubiquitin in an ATP-dependent manner. Although thought for many years that there was only one mammalian E1, a second E1 was recently discovered [5]. The ubiquitin is then transferred from the E1 to a cysteine residue of an ubiquitin-conjugating enzyme or E2. There are more than 30 mammalian E2s. Finally an E3 ubiquitin ligase facilitates the transfer of ubiquitin typically to an ε-NH 2 group of a lysine residue of the substrate thus making an isopeptide bond. There are hundreds of mammalian E3s, most of which contain RING domains composed of characteristically spaced conserved cysteine and histidine residues that form a zinc binding 'cross-brace structure ' [6]. RING type E3s are non-enzymatic and are thought to facilitate the transfer of ubiquitin from the charged E2 to their substrates by bringing them in Corresponding Author: Ted Hansen, Tel:314-362-2716, Fax: 314-362-4137, E-mail: hansen@wustl.edu. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note t...